110 related articles for article (PubMed ID: 2768543)
41. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Otani K; Kaneko S
Pharmacol Toxicol; 2001 May; 88(5):267-70. PubMed ID: 11393588
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of trazodone during multiple dosing to psychiatric patients.
Nilsen OG; Dale O; Husebø B
Pharmacol Toxicol; 1993; 72(4-5):286-9. PubMed ID: 8372048
[TBL] [Abstract][Full Text] [Related]
43. Trazodone--a comparison of single night-time and divided daily dosage regimens.
Brooks D; Prothero W; Bouras N; Bridges PK; Jarman CM; Ankier SI
Psychopharmacology (Berl); 1984; 84(1):1-4. PubMed ID: 6436874
[TBL] [Abstract][Full Text] [Related]
44. Serotonin syndrome produced by paroxetine and low-dose trazodone.
Reeves RR; Bullen JA
Psychosomatics; 1995; 36(2):159-60. PubMed ID: 7724720
[No Abstract] [Full Text] [Related]
45. Desipramine plasma concentration and antidepressant response.
Nelson JC; Jatlow P; Quinlan DM; Bowers MB
Arch Gen Psychiatry; 1982 Dec; 39(12):1419-22. PubMed ID: 7149903
[TBL] [Abstract][Full Text] [Related]
46. [Brief depressive affect].
Gertz HJ
Nervenarzt; 1992 Jan; 63(1):50-1. PubMed ID: 1570041
[TBL] [Abstract][Full Text] [Related]
47. Trazodone-induced transient hypomanic symptoms and their management.
Jabeen S; Fisher CJ
Br J Psychiatry; 1991 Feb; 158():275-8. PubMed ID: 2012922
[TBL] [Abstract][Full Text] [Related]
48. Trazodone treatment increases plasma prolactin concentrations in depressed patients.
Otani K; Yasui N; Kaneko S; Ishida M; Ohkubo T; Osanai T; Sugawara K; Fukushima Y
Int Clin Psychopharmacol; 1995 Jun; 10(2):115-7. PubMed ID: 7673654
[TBL] [Abstract][Full Text] [Related]
49. A combination of hypothalamic phospholipid liposomes with trazodone for treatment of depression. An open controlled study.
Giannelli A; Rabboni M; Zarattini F; Malgeri C; Magnolfi G
Acta Psychiatr Scand; 1989 Jan; 79(1):52-8. PubMed ID: 2648767
[TBL] [Abstract][Full Text] [Related]
50. The role of trazodone in the treatment of depressed cardiac patients.
Himmelhoch JM; Schechtman K; Auchenbach R
Psychopathology; 1984; 17 Suppl 2():51-63. PubMed ID: 6201941
[TBL] [Abstract][Full Text] [Related]
51. Preliminary data on the relationship between nortriptyline plasma level and response in depressed children.
Geller B; Cooper TB; Chestnut EC; Anker JA; Schluchter MD
Am J Psychiatry; 1986 Oct; 143(10):1283-6. PubMed ID: 3532829
[TBL] [Abstract][Full Text] [Related]
52. Insights in the use of trazodone in depressed patients.
Gershon S
J Clin Psychiatry; 1990 Sep; 51 Suppl():4-5. PubMed ID: 2211566
[No Abstract] [Full Text] [Related]
53. Trazodone in endogenous depressed patients: a negative report and a critical evaluation of the pertaining literature.
Klein HE; Müller N
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):173-86. PubMed ID: 4001432
[TBL] [Abstract][Full Text] [Related]
54. Augmentation of antidepressant therapy by buspirone: three geriatric case histories.
Robillard M; Lieff S
Can J Psychiatry; 1995 Dec; 40(10):639-40. PubMed ID: 8681264
[No Abstract] [Full Text] [Related]
55. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
Otani K; Tybring G; Mihara K; Yasui N; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
[TBL] [Abstract][Full Text] [Related]
56. A comparative study of conventional and controlled-release formulations of trazodone in elderly depressed patients.
Bayer AJ; Pathy MS; Cameron A; Venkateswalu T; Ather SA; Mankikar GD; Ghosh AK
Clin Neuropharmacol; 1989; 12 Suppl 1():S50-5; Discussion S56-7. PubMed ID: 2663153
[TBL] [Abstract][Full Text] [Related]
57. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol.
Mihara K; Otani K; Ishida M; Yasui N; Suzuki A; Ohkubo T; Osanai T; Kaneko S; Sugawara K
Ther Drug Monit; 1997 Feb; 19(1):43-5. PubMed ID: 9029745
[TBL] [Abstract][Full Text] [Related]
58. Neuroendocrinological and clinical data upon trazodone treatment in depressed patients.
Roccatagliata G; Murialdo G; Albano C; Giovale M; Zauli C; Polleri A
Neuropsychobiology; 1982; 8(5):259-68. PubMed ID: 7133375
[TBL] [Abstract][Full Text] [Related]
59. Trazodone-oral cocaine interactions.
Rowbotham MC; Jones RT; Benowitz NL; Jacob P
Arch Gen Psychiatry; 1984 Sep; 41(9):895-9. PubMed ID: 6380447
[TBL] [Abstract][Full Text] [Related]
60. Clinical experience with antidepressive infusion therapy: trazodone.
Berzewski H
Psychopharmacology (Berl); 1988; 95 Suppl():S31-3. PubMed ID: 3133711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
